Are high drug loading nanoparticles the next step forward for chemotherapy?

Nanomedicine

Volumn 7, Issue 3, 2012, Pages 303-305

  Della Rocca, Joseph ^a   Liu, Demin ^a   Lin, Wenbin ^a,b  

^a The University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

cancer; chemotherapy; nanocrystal; nanomedicine; nanoscale coordination polymer

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CREMOPHOR; DOXORUBICIN; DRUG CARRIER; GEMCITABINE; NANOCRYSTAL; PACLITAXEL; PIPOSULFAN; POLYMER; POLYSILSESQUIOXANE; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CLINICAL RESEARCH; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; HUMAN; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VALIDATION STUDY;

ANTINEOPLASTIC AGENTS; DRUG CARRIERS; HUMANS; NANOPARTICLES; NEOPLASMS;

EID: 84863288967     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.191     Document Type: Review

References (19)

1. Cancer Facts and Figures 2011. In: The American Cancer Society Factbook. American Cancer Society, GA, USA (2011).
2. Bawa R. Patents and nanomedicine. Nanomedicine (Lond.) 2(3), 351-374 (2007).
3. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 23(1-3), 3-25 (1997).
4. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12), 751-760 (2007).
5. Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of anticancer drugs. Annu. Rev. Med. 63, 185-198 (2012).
6. Judson I, Radford JA, Harris M et al. Randomised Phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: A study by the EORTC soft tissue and bone sarcoma group. Eur. J. Cancer 37(7), 870-877 (2001).
7. O'Brien MER, Wigler N, Inbar M et al. Reduced cardiotoxicity and comparable efficacy in a Phase III trial of pegylated liposomal doxorubicin HCL (CAELYXTM/DoxilR) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Anal. Oncol. 15(3), 440-449 (2004).
8. Liu F, Park J-Y, Zhang Y et al. Targeted cancer therapy with novel high drug-loading nanocrystals. J. Pharm. Sci. 99(8), 3542-3551 (2010).
9. Dobrovolskaia MA, Germolec DR, Weaver JL. Evaluation of nanoparticle immunotoxicity. Nat. Nanotechnol. 4(7), 411-414 (2009).
10. Akiyama Y, Mori T, Katayama Y, Niidome T. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in tumor bearing mice. J. Control. Release 139(1), 81-84 (2009).
11. Panagi Z, Beletsi A, Evangelatos G, Livaniou E, Ithakissios DS, Avgoustakis K. Effect of dose and the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanopaticles. Int. J. Pharm. 221(1-2), 143-152 (2001).
12. Muller RH, Gohla S, Keck CM. State of the art of nanocrystals-special features, production, nanotoxicology aspects and intracellular delivery. Eur. J. Pharm. Biopharm. 78(1), 1-9 (2011).
13. Rabinow BE. Nanosuspensions in drug delivery. Nat. Rev. Drug Discovery 3(9), 785-796 (2004).
14. Merisko-Liversidge E, Sarpotdar P, Bruno J et al. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm. Res. 13(2), 272-278 (1996).
15. Della Rocca J, Liu D, Lin W. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery. Acc. Chem. Res. 44(10), 957-968 (2011).
16. Huxford RC, Dekrafft KE, Boyle WS, Liu D, Lin W. Lipid-coated nanoscale coordination polymers for targeted delivery of antifolates to cancer cells. Chem. Sci. 3, 198-204 (2012).
17. Rieter WJ, Pott KM, Taylor KML, Lin W. Nanoscale coordination polymers for platinum-based anticancer drug delivery. J. Am. Chem. Soc. 130(35), 11584-11585 (2008).
18. Taylor-Pashow KML, Della Rocca J, Xie Z, Tran S, Lin W. Post-synthetic modifications of iron-carboxylate nanoscale metal-organic frameworks for imaging and drug delivery. J. Am. Chem. Soc. 131(40), 14261-14263 (2009).
19. Della Rocca J, Huxford RC, Comstock-Duggan E, Lin W. Polysilsesquioxane nanoparticles for targeted platin-based cancer chemotherapy by triggered release. Angew. Chem. Int. Ed. 50(44), 10330-10334 (2011).